Moreover, the results of RT–qPCR and western blotting validated the upregulated expression of Smad2 in the MASLD (P < 0.001) and MASLD + OSA (P < 0.001) groups (Fig. 4h–i). Here, SMAD2 is linked to obstructive sleep apnea syndrome.